3 reports

Major players in the clinical oncology next-generation sequencing market are Thermo Fisher Scientific (Qiagen), Oxford Nanopore Technologies, QIAGEN, Myriad Genetics, Illumina, F. Hoffmann-La Roche, Perkin Elmer, Agilent Technologies, Pacific Bioscience, and Caris Life Sciences. The global clinical oncology next generation sequencing...

  • Cancer
  • DNA Sequencing
  • World
  • APAC
  • Cancer Incidence
  • Cancer Mortality

Major players in the clinical oncology next generation sequencing market are Thermo Fisher Scientific (Qiagen), Oxford Nanopore Technologies, QIAGEN, Myriad Genetics, Illumina, F. Hoffmann-La Roche, Perkin Elmer, Agilent Technologies, Pacific Bioscience, and Caris Life Sciences. The global clinical oncology next generation sequencing...

  • Diagnostics
  • Public Health
  • Genome Sequencing
  • Drug Development
  • DNA Sequencing
  • Telecommuting
  • Breast Cancer
  • Cell Therapy
  • Industrial Automation
  • Oncology
  • World
  • APAC
  • Cancer Incidence
  • Cancer Mortality

DNA sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Other Applications), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-Time...

  • Genomics
  • Reproductive Health
  • Nanotechnology
  • DNA Sequencing
  • Pharmaceutical
  • Biotechnology
  • Biomarker
  • World
  • APAC
  • Disposable Income